Evaluation of flurbiprofen removal from aqueous solution by electrosynthesized ferrate(VI) ion and electrocoagulation process

Chemical Engineering Journal

Volumn 262, Issue , 2015, Pages 1218-1225

  Barişçi, Sibel ^a   Ulu, Feride ^a   Sillanpää, Mika ^b   Dimoglo, Anatholy ^a  

^a GEBZE TECHNICAL UNIVERSITY   (Turkey)

^b LAPPEENRANTA UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Electrocoagulation (EC); Ferrate(VI); Flurbiprofen; Oxidation; Pharmaceuticals

Indexed keywords

COAGULATION; DRUG PRODUCTS; OXIDATION;

CHARGE NEUTRALIZATION; ELECTRO COAGULATIONS; ELECTROCOAGULATION; EQUILIBRIUM CONCENTRATION; FERRATE; FLURBIPROFEN; INITIAL CONCENTRATION; REMOVAL EFFICIENCIES;

DRUG DOSAGE;

EID: 84909992709     PISSN: 13858947     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cej.2014.10.083     Document Type: Article

References (49)

1. Quevauviller P., Balabanis P., Fragakis C., Weydert M., Oliver M., Kaschl A., Arnold G., Kroll A., Galbiati L., Zaldivar J.M. Science-policy integration needs in support of the implementation of the EU Water Framework Directive. Environ. Sci. Pol. 2005, 8:203-211.
2. Daughton C.G., Ruhoy I.S. Environmental footprint of pharmaceuticals: the significance of factors beyond direct excretion to sewers. Environ. Toxicol. Chem. 2009, 28:2495-2521.
3. Glassmeyer S.T., Furlong E.T., Kolpin D.W., Cahill J.D., Zaugg S.D., Werner S.L., Meyer M.T., Kryak D.D. Transport of chemical and microbial compounds from known wastewater discharges: potential for use as indicators of human fecal contamination. Environ. Sci. Technol. 2005, 39:5157-5169.
4. Lin A.Y.-C., Yu T.-H., Lateef S.K. Removal of pharmaceuticals in secondary wastewater treatment processes in Taiwan. J. Hazard. Mater. 2009, 167:1163-1169.
5. Langford K.H., Thomas K.V. Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works. Environ. Int. 2009, 35:766-770.
6. Du B., Price A.E., Scott W.C., Kristofco L.A., Ramirez A.J., Chambliss C.K., Yelderman J.C., Brooks B.W. Comparison of contaminants of emerging concern removal, discharge, and water quality hazards among centralized and on-site wastewater treatment system effluents receiving common wastewater influent. Sci. Total Environ. 2014, 466:976-984.
7. Brodin T., Fick J., Jonsson M., Klaminder J. Dilute concentrations of a psychiatric drug alter behavior of fish from natural populations. Science 2013, 339:814-815.
8. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change. Environ. Health Persp. 1999, 107:907.
9. Anthony C. Moffat, M. David Osselton, Brian Widdop, Clarcke's Analysis of Drugs and Poisons in Pharmaceuticals, third ed., Body Fluids and Postmortem Materials, vol. 2, Pharmaceutical Press, London, UK, 2004, p. 1056.
10. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. 2002, 131:5-17.
11. Hua W., Bennett E.R., Letcher R.J. Ozone treatment and the depletion of detectable pharmaceuticals and atrazine herbicide in drinking water sourced from the upper Detroit River, Ontario, Canada. Water Res. 2006, 40:2259-2266.
12. Zhang Y., Geißen S.-U., Gal C. Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. Chemosphere 2008, 73:1151-1161.
13. Kümmerer K. Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks 2008, Springer.
14. Okuda T., Kobayashi Y., Nagao R., Yamashita N., Tanaka H., Tanaka S., Fujii S., Konishi C., Houwa I. Removal efficiency of 66 pharmaceuticals during wastewater treatment process in Japan. Water Sci. Technol. 2008, 57.
15. Esplugas S., Bila D.M., Krause L.G.T., Dezotti M. Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents. J. Hazard. Mater. 2007, 149:631-642.
16. Mohapatra D.P., Brar S.K., Tyagi R.D., Picard P., Surampalli R.Y. Analysis and advanced oxidation treatment of a persistent pharmaceutical compound in wastewater and wastewater sludge-carbamazepine. Sci. Total Environ. 2014, 470-471:58-75.
17. F.C. Moreira, S. Garcia-Segura, R.A.R. Boaventura, E. Brillas, V.J.P. Vilar, Degradation of the antibiotic trimethoprim by electrochemical advanced oxidation processes using a carbon-PTFE air-diffusion cathode and a boron-doped diamond or platinum anode, Appl. Catal. B 160-161 (2014) 492-505.
18. Aguinaco A., Beltrán F.J., Sagasti J.J.P., Gimeno O. In situ generation of hydrogen peroxide from pharmaceuticals single ozonation: a comparative study of its application on Fenton like systems. Chem. Eng. J. 2014, 235:46-51.
19. Hou L., Zhang H., Wang L., Chen L., Xiong Y., Xue X. Removal of sulfamethoxazole from aqueous solution by sono-ozonation in the presence of a magnetic catalyst. Sep. Purif. Technol. 2013, 117:46-52.
20. Comerton A.M., Andrews R.C., Bagley D.M., Hao C. The rejection of endocrine disrupting and pharmaceutically active compounds by NF and RO membranes as a function of compound and water matrix properties. J. Membr. Sci. 2008, 313:323-335.
21. Snyder S.A., Adham S., Redding A.M., Cannon F.S., DeCarolis J., Oppenheimer J., Wert E.C., Yoon Y. Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals. Desalination 2007, 202:156-181.
22. Mittal A., Kurup L., Mittal J. Freundlich and Langmuir adsorption isotherms and kinetics for the removal of Tartrazine from aqueous solutions using hen feathers. J. Hazard. Mater. 2007, 146:243-248.
23. Cabrera-Lafaurie W.A., Román F.R., Hernández-Maldonado A.J. Removal of salicylic acid and carbamazepine from aqueous solution with Y-zeolites modified with extraframework transition metal and surfactant cations: equilibrium and fixed-bed adsorption. J. Environ. Chem. Eng. 2014, 2:899-906.
24. 4 nanoparticles bearing aminated β-cyclodextrin. J. Environ. Chem. Eng. 2013, 1:122-130.
25. Jiang J.-Q., Wang S., Panagoulopoulos A. The role of potassium ferrate (VI) in the inactivation of Escherichia coli and in the reduction of COD for water remediation. Desalination 2007, 210:266-273.
26. Jiang J.-Q., Wang S., Panagoulopoulos A. The exploration of potassium ferrate (VI) as a disinfectant/coagulant in water and wastewater treatment. Chemosphere 2006, 63:212-219.
27. Jiang J.-Q., Zhou Z., Pahl O. Preliminary study of ciprofloxacin (cip) removal by potassium ferrate (VI). Sep. Purif. Technol. 2012, 88:95-98.
28. Ulu F., Barişçi S., Sarkka H., Kobya M., Sillanpaa M. Removal of humic substances by electrocoagulation (EC) process and characterization of floc size growth mechanism under optimum conditions. Sep. Purif. Technol. 2014, 133:246-253.
29. Y.A. Ouaissa, M. Chabani, A. Amrane, Hem A. Bensmaili, Removal of tetracycline by electrocoagulation: kinetic and isotherm modeling through adsorption, J. Environ. Chem. Eng. 2 (2014) 177-184.
30. Vasudevan S., Lakshmi J., Sozhan G. Studies on the Al-Zn-In-alloy as anode material for the removal of chromium from drinking water in electrocoagulation process. Desalination 2011, 275:260-268.
31. Merzouk B., Gourich B., Sekki A., Madani K., Vial Ch., Barkaoui M. Studies on the decolorization of textile dye wastewater by continuous electrocoagulation process. Chem. Eng. J. 2009, 149:207-214.
32. Barişçi S., Ulu F., Sarkka H., Dimoglo A., Sillanpaa M. Electrosynthesis of ferrate(VI) ion using high purity iron electrodes: optimization of influencing parameters on the process and investigating its stability. Int. J. Electrochem. Sci. 2014, 9:3099-3107.
33. Alaton I.A., Dogruel S., Baykal E., Gerone G. Combined chemical and biological oxidation of penicillin formulation effluent. J. Environ. Manage. 2004, 73:155-163.
34. 2 photocatalysis. J. Environ. Manage. 2012, 98:168-174.
35. Brillas E., Sirés I., Arias C., Cabot P.L., Centellas F., Rodríguez R.M., Garrido J.A. Mineralization of paracetamol in aqueous medium by anodic oxidation with a boron-doped diamond electrode. Chemosphere 2005, 58:399-406.
36. González T., Domínguez J.R., Palo P., Sánchez-Martín J. Conductive-diamond electrochemical advanced oxidation of naproxen in aqueous solution: optimizing the process. J. Chem. Technol. Biotechnol. 2011, 86:121-127.
37. 2 and Si/BDD electrodes. Electrochim. Acta 2009, 54:1464-1472.
38. Zhao X., Hou Y., Liu H., Qiang Z., Qu J. Electro-oxidation of diclofenac at boron doped diamond: kinetics and mechanism. Electrochim. Acta 2009, 54:4172-4179.
39. Meloun M., Bordovská S., Galla L. The thermodynamic dissociation constants of four non-steroidal anti-inflammatory drugs by the least-squares nonlinear regression of multiwavelength spectrophotometric pH-titration data. J. Pharmaceut. Biomed. 2007, 45:552-564.
40. Li P., Zhao L. Solubilization of flurbiprofen in pH-surfactant solutions. J. Pharm. Sci. 2003, 92:951-956.
41. Pehourcq F., Jarry C., Bannwarth B. Chiral resolution of flurbiprofen and ketoprofen enantiomers by HPLC on a glycopeptide-type column chiral stationary phase. Biomed. Chromatogr. 2001, 15:217-222.
42. Sharma V.K., Burnett C.R., Millero F.J. Dissociation constants of the monoprotic ferrate(VI) ion in NaCl media. Phys. Chem. Chem. Phys. 2001, 3:2059-2062.
43. Sono M., Roach M.P., Coulter E.D., Dawson J.H. Heme-containing oxygenases. Chem. Rev. 1996, 96:2841-2888.
44. Meunier B., De Visser S.P., Shaik S. Mechanism of oxidation reactions catalyzed by cytochrome P450 enzymes. Chem. Rev. 2004, 104:3947-3980.
45. Sharma V.K., Luther G.W., Millero F.J. Mechanisms of oxidation of organosulfur compounds by ferrate(VI). Chemosphere 2011, 82:1083-1089.
46. Sharma V.K. Ferrate(VI) and ferrate(V) oxidation of organic compounds: kinetics and mechanism. Coord. Chem. Rev. 2013, 257:495-510.
47. M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, J.A. Montgomery, Jr., T. Vreven, K.N. Kudin, J.C. Burant, J.M. Millam, S.S. Iyengar, J. Tomasi, V. Barone, B. Mennucci, M. Cossi, G. Scalmani, N. Rega, G.A. Petersson, H. Nakatsuji, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, M. Klene, X. Li, J.E. Knox, H.P. Hratchian, J.B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R.E. Stratmann, O. Yazyev, A.J. Austin, R. Cammi, C. Pomelli, J.W. Ochterski, P.Y. Ayala, K. Morokuma, G.A. Voth, P. Salvador, J.J. Dannenberg, V.G. Zakrzewski, S. Dapprich, A.D. Daniels, M.C. Strain, O. Farkas, D.K. Malick, A.D. Rabuck, K. Raghavachari, J.B. Foresman, J.V. Ortiz, Q. Cui, A.G. Baboul, S. Clifford, J. Cioslowski, B.B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R.L. Martin, D.J. Fox, T. Keith, M.A. Al-Laham, C.Y. Peng, A. Nanayakkara, M. Challacombe, P.M.W. Gill, B. Johnson, W. Chen, M.W. Wong, C. Gonzalez, J.A. Pople, Gaussian 03, Revision B.05, Gaussian Inc., Wallingford, CT, 2004.
48. Tsitsimpikou C., Spyridaki M.H.E., Georgoulakis I., Kouretas D., Konstantinidou M., Georgakopoulos C.G. Elimination profiles of flurbiprofen and its metabolites in equine urine for doping analysis. Talanta 2001, 55:1173-1180.
49. Dubrawski K.L., Fauvel M., Mohseni M. Metal type and natural organic matter source for direct filtration electrocoagulation of drinking water. J. Hazard. Mater. 2013, 244-245:135-141.